Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...

The Korea Research Institute of Standards and Science has successfully developed a nanomaterial capable of simultaneously ...

Explore how the ratio of pd-1+ treg to ctl and the presence of tertiary lymphoid structures can influence treatment outcomes ...

Researchers at the School of Chinese Medicine, LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have found that ...

Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow - and how blocking them could ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) ...

Regeneron Pharmaceuticals gains FDA approval for Lynozyfic drug targeting multiple myeloma, with launch details and executive ...

Studies presented at the ASCO Annual Meeting 2025 highlighted immunotherapies that may provide new standards of care for certain cancers as well as immunotherapies that are breaking new ground by ...

A new way to grow stem cells may help them release more of the signaling proteins they use to repair tissue, potentially improving future ...

A new frontier in orthopaedics is offering hope to millions struggling with joint pain, not by dulling the symptoms, but by repairing the damage itself. Read all about regenerative therapies.